Home > News > Recent cases

Regen Lab SA v Estar Medical and ors [2019] EWHC 63 (Pat)18 January 2019Andrew Lykiardopoulos QC appeared alongside Michael Conway and Tim Bamford of Collyer Bristow, for the Claimant (“Regen”), in this action concerning Regen’s patent for the preparation of platelet rich blood plasma (PRP). Regen claimed that that the patent was infringed by the Defendant’s PRP kits. The Defendants (“Estar”) denied infringement and counterclaimed for revocation, alleging […]
Glaxo Group Ltd and Ors v Vectura Ltd [2018] EWHC 3414 (Pat)13 December 2018Andrew Lykiardopoulos QC, alongside Anna Edwards-Stuart of 11 South Square, appeared for the Defendant, the proprietor of five patents concerning both the manufacture of particles to be used in pharmaceutical compositions for inhalation and the compositions themselves. The Defendant alleged that the Claimants had infringed its patents by the manufacture and sale of certain dried […]
Warner Lambert v Generics (UK) t/a Mylan [2018] UKSC 5614 November 2018Adrian Speck QC, alongside Pushpinder Saini QC of Blackstone Chambers and Kathryn Pickard of 11 South Square, appeared for the Respondents in Warner-Lambert’s appeal to the Supreme Court regarding their Swiss-form patent for the drug pregabalin. The appeal raised important questions concerning the role of plausibility in the test for insufficiency and the determination of […]
British Broadcasting Corporation and BBC Worldwide Ltd v Mechanical-Copyright Protection Society Ltd and Performing Right Society Ltd; Sky Ltd and ITV Networks Ltd intervening [2018] EWHC 2931 (Ch)6 November 2018Lindsay Lane, alongside Rhodri Thompson QC of Matrix Chambers, appeared for the Respondents, the BBC. Martin Howe QC and Michael Conway appeared for Sky, intervening. The appeal related to decision of the Copyright Tribunal on a preliminary issue in a reference brought by the BBC, concerning the Tribunal’s jurisdiction to settle the terms of copyright […]
Astex Therapeutics v AstraZeneca AB [2018] EWCA Civ 24446 November 2018The Court of Appeal upheld the decision of the trial judge in favour of AstraZeneca in relation to a contractual drug development dispute. The parties had engaged in a collaborative research program (the Program) aimed at identifying a drug suitable for inhibiting the BACE enzyme, thought to be involved in the development of Alzheimer’s disease. […]